BioMark gets US patent for liquid biopsy technology

Stock Information for BioMark Diagnostics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BioMark Diagnostics Inc

BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
BioMark Diagnostics Announces Uplisting to OTCQB Venture Market
BioMark Announces the Final Closing of Oversubscribed Private Placement
BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025
BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction
BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.